Back to Results
First PageMeta Content



Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in
Add to Reading List

Document Date: 2015-06-12 10:36:45


Open Document

File Size: 650,01 KB

Share Result on Facebook
UPDATE